← Back to Search

Behavioral Intervention

Online System for Teen Substance Abuse (Substance Trial)

N/A

Waitlist Available

Led By Raymond Sturner, MD

Research Sponsored by Total Child Health, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

English speaking and reading

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from day 0 to 11.5 months

Awards & highlights

Substance Trial Summary

This trial will test whether the CHADIS c-SBI Module can help PCPs to address teen substance use by providing guidance on how to have a patient focused discussion with teens.

Who is the study for?

This trial is for English-speaking teens with substance use disorders. It's designed to help primary care providers improve how they address teen substance abuse during routine check-ups and follow-up care.Check my eligibility

What is being tested?

The trial tests a new module in the CHADIS system, which includes pre-visit screening tools for substance use, reminders about goals for change, and teleprompter interview hints to aid doctors in motivational interviewing.See study design

What are the potential side effects?

Since this intervention involves educational tools and not medical treatments, traditional side effects are not applicable. However, there may be emotional or psychological impacts from discussing sensitive topics.

Substance Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can speak and read English.

Substance Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from day 0 to 11.5 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from day 0 to 11.5 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from day 0 to 11.5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Substance use at one year

Substance use level

Secondary outcome measures

Riding/driving risky behavior

Substance Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: computerized Substance Brief Intervention cSBIExperimental Treatment1 Intervention

Enhanced care PCPs will address the serious morbidity of teen substance use during routine check-up visits using cSBI and follow up care using a new Module of CHADIS that facilitates guideline-based care. The CHADIS c-SBI Module will include pre-visit screening tools and embedded education that cover substance use and strengths and goals. It will also include reminders to the patient about their goals and commitments for change and teleprompted interview hints for the PCP. These hints will be aimed at enhancing a patient focused discussion of individual strengths and barriers related to the teens' goals in a motivational interviewing style.

Group II: Standard careActive Control1 Intervention

Standard care PCPs will screen using a standard SU tool and carry out their usual health supervision visits without additional decision support.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Total Child Health, Inc.Lead Sponsor

3 Previous Clinical Trials

17,210 Total Patients Enrolled

Boston Children's HospitalOTHER

761 Previous Clinical Trials

5,574,730 Total Patients Enrolled

7 Trials studying Substance Abuse

860 Patients Enrolled for Substance Abuse

Raymond Sturner, MDPrincipal InvestigatorCenter for Promotion of Child Devlopment

1 Previous Clinical Trials

16,630 Total Patients Enrolled

Media Library

cSBI (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04689997 — N/A

Substance Abuse Research Study Groups: computerized Substance Brief Intervention cSBI, Standard care

Substance Abuse Clinical Trial 2023: cSBI Highlights & Side Effects. Trial Name: NCT04689997 — N/A

cSBI (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04689997 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For which patient demographic is this clinical trial open?

"To qualify for this trial, participants must have a history of substance misuse and be between 12 to 19 years old. In total, there is a need for 5000 individuals who meet these criteria."

Answered by AI

What is the upper limit on participants for this research project?

"Affirmative. The clinical trial portal has evidence that recruitment for this experiment is ongoing; it was initially announced on February 1st 2021 and most recently updated on March 16th 2022. 5,000 individuals are required to be enrolled at a single medical centre."

Answered by AI

Is there an ongoing opportunity for individuals to participate in this trial?

"The information listed on clinicaltrials.gov asserts that recruitment is current ongoing for this trial, which was posted initially in February 2021 and edited most recently 16 March 2022."

Answered by AI